PBS Biotech secures $17 million in follow-on round
One year after the company raised $22 million in financing, Camarillo-based PBS Biotech secured another $17 million in follow-on growth capital from Avego Management and BroadOak Capital Partners. Announced Jan. 6, the investment will help accelerate PBS Biotech’s new product innovation, process development services, and quality system improvements, further advancing the cell therapy industry and helping their Read More →
A2 Bio closes $80 million Series C financing round
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital. A2 Bio is developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells. Proceeds Read More →
805 Tech: Region’s investments in AI will continue paying off
Let’s get this out of the way now. If you got tired of hearing about artificial intelligence and how it is going to revolutionize our way of life, well, fair warning, that isn’t going to stop in 2025. In fact, that’s probably the majority of tech trends you’re going to hear about — and the Central Read More →
Reaching new heights: Pearce Services adds new capabilities after record acquisition
Fifteen years ago, Paso Robles-based Pearce Services was just breaking into the middle market company space, hitting key markers with about $10 million in revenue and over 50 employees. But after 2010, the company started entering new markets, growing at a rapid pace. So much so that in 2024, the company now employs over 3,500 people and Read More →
Will the region’s top stocks keep dominating in 2025?
The tri-county region enters 2025 with 33 publicly traded companies headquartered here, with more than two dozen of those trading on the New York Stock Exchange or the NASDAQ. Of those, five companies have market capitalizations higher than $9 billion and are some of the biggest players in their respective industries. Here’s a look at Read More →
Inogen’s newest respiratory device gains FDA clearance
Goleta-based Inogen, a medical technology specializing in the manufacturing of portable oxygen containers, announced Dec. 30 that it had received U.S. Food and Drug Administration clearance for the Simeox 200 Airway Clearance Device. The clearance helps expand the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the Read More →
Teledyne completes $58M takeover of Micropac
Thousand Oaks-based Teledyne Technologies completed its acquisition of Micropac Industries on Dec. 30. The all-cash transaction valued Micropac at approximately $57.3 million, taking into account Micropac’s net debt as of Aug. 24. Under the merger agreement’s terms, Micropac stockholders received $20 per share in cash. “We are delighted to welcome Micropac and its employees to Read More →
